| Company Name: | LeMaitre Vascular, Incorporated | | Ticker Symbol: | LMAT | | | WWW Address: | www.lemaitre.com | | CEO: | George W. LeMaitre | | No. of Employees: | 200 | | Common Issue Type: | CS | | Business Description: | The Company develops, manufactures and markets vascular devices to address the needs of vascular surgeons.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 4.89 |  0.01 | 4.83 | 4.89 | 4.89 | 4.88 | 4.70 | 100 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 76.8 | 15.7 | 0.86 | -0.21 | 0.00 | 122.0 | 0.0 | 5.00 - 1.54 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 4.88 | $ | | PE Ratio - LTM | 122.0 | |
| Market Capitalisation | 76.7 | mil |
| Latest Shares Outstanding | 15.7 | mil |
| Earnings pS (EPS) | -0.21 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 243,600 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 10.3 | mil |
| Float as % of Shares Outstanding | 65.4 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 54.60 | % |
| Research & Devlopment (R&D) as % of Revenue | 11.10 | % |
| Gross Profit Margin | 74.8 | % |
| EBITDA Margin | 9.1 | % |
| Pre-Tax Profit Margin | 2.4 | % |
| Assets Turnover | 0.9 | % |
| Return on Assets (ROA) | 1.1 | % |
| Return on Equity (ROE) | 1.4 | % |
| Return on Capital Invested (ROCI) | 1.3 | % |
| Current Ratio | 5.6 | |
| Leverage Ratio (Assets/Equity) | 1.2 | |
| Interest Cover | 28.8 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 2.02 | $ |
| Cash pS | 1.26 | $ |
| Book-Value pS | 3.01 | $ |
| Tangible Book-Value pS | 2.09 | $ |
| Cash Flow pS | 0.13 | $ |
| Free Cash Flow pS | 0.23 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.62 | |
| Price/Tangible Book Ratio | 2.34 | |
| Price/Cash Flow | 36.9 | |
| Price/Free Cash Flow | 21.5 | |
| P/E as % of Industry Group | 431.0 | % |
| P/E as % of Sector Segment | 243.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -2.4 | 98 | 882 | 3,917 |
| 4 Weeks | 5.00 | 4.12 | 4.25 | 14.8 | 114 | 654 | 13,080 |
| 13 Weeks | 5.00 | 3.32 | 3.51 | 39.0 | 131 | 265 | 16,957 |
| 26 Weeks | 5.00 | 2.70 | 2.84 | 71.8 | 140 | 188 | 23,833 |
| 52 Weeks | 5.00 | 1.54 | 2.58 | 89.1 | 139 | 164 | 41,138 |
| YTD | 5.00 | 1.54 | - | 111.4 | 175 | 175 | 39,483 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 4.80 | 4.72 | 4.23 | 3.53 | 3.22 | 0.86 | 0.86 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 15.64 | 96.7 | 12.81 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 6.68 |
| R&D | 0.00 | NA | 18.92 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 2.0 | 11.0 | 17.6 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.25 | 0.09 | -0.02 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 55.48 |
| Current Ratio | 5.4 |
| Quick Ratio (Acid Test) | 4.1 |
| Liquidity Ratio (Cash) | 3.07 |
| Receivables Turnover | 6.8 |
| Average Collection Period | 53 |
| Working Capital/Equity | 66.0 |
| Working Capital pS | 1.93 |
| Cash-Flow pS | -0.11 |
| Free Cash-Flow pS | -0.06 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 6.63 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 15.9 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 3.7 |
| LT Debt/Total Liabilities | 0.9 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.13 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.77 |
| Tobin's Q Ratio | 1.41 |
| Current P/E Ratio - LTM | 122.00 |
| Enterprise Value (EV)/EBITDA | 157.56 |
| Enterprise Value (EV)/Free Cash Flow | -105.04 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 2.34 |
| Price/Book Ratio - LTM | 1.62 |
| Price/Cash Flow Ratio | 36.9 |
| Price/Free Cash Flow Ratio - LTM | 21.5 |
| Price/Sales Ratio | 1.55 |
| P/E Ratio (1 month ago) - LTM | 105.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 431.0 |
| P/E as % of Sector Segment | 243.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 31.3 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.44 |
| Tangible Book Value pS - LTM | 2.09 |
| Book Value pS - LTM | 3.01 |
| Capital Invested pS | 2.91 |
| Cash pS - LTM | 1.26 |
| Cash Flow pS - LTM | 0.13 |
| Free Cash Flow pS - LTM | 0.23 |
| Earnings pS (EPS) | -0.21 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -2.04 |
| Free Cash Flow Margin 5YEAR AVG | -7.92 |
| Net Profit Margin | -6.8 |
| Net Profit Margin - 5YEAR AVRG. | -3.5 |
| Equity Productivity | 1.06 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.06 |
| Return on Capital Invested (ROCI) | -7.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -3.6 |
| Assets Productivity | 0.80 |
| Return on Assets (ROA) | -6.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | -3.0 |
| Gross Profit Margin | 74.8 |
| Gross Profit Margin - 5YEAR AVRG. | 75.1 |
| EBITDA Margin - LTM | 9.1 |
| EBIT Margin - LTM | 2.4 |
| Pre-Tax Profit Margin | -5.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -2.4 |
| Effective Tax Rate | -17.5 |
| Effective Tax Rate - 5YEAR AVRG. | -8.4 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 279 |
| Revenue per Employee | 243,600 |
| Net Income per Employee | -16,570 |
| Average Collection Period | 54 |
| Receivables Turnover | 6.8 |
| Day's Inventory Turnover Ratio | 225 |
| Inventory Turnover | 1.6 |
| Inventory/Sales | 14.3 |
| Accounts Payble/Sales | 1.24 |
| Assets/Revenue | 1.25 |
| Net Working Capital Turnover | 1.61 |
| Fixed Assets Turnover | 2.82 |
| Total Assets Turnover | 0.8 |
| Revenue per $ Cash | 3.07 |
| Revenue per $ Plant | 20.94 |
| Revenue per $ Common Equity | 1.06 |
| Revenue per $ Capital Invested | 1.06 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 61.1 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 62.2 |
| Research & Devlopment (R&D) as % of Revenue | 10.9 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 10.9 |
|
|  
|
| |
 |  |